These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 11366205)
1. Fat, sugar and drugs on the French Riviera. Lands L GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205 [TBL] [Abstract][Full Text] [Related]
2. Are changes in body shape due to drug side effects? TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790 [TBL] [Abstract][Full Text] [Related]
3. HAL in 2001: a fat oddity. Grinberg L; Torres G GMHC Treat Issues; 1999 Mar; 13(3):2-5, 8. PubMed ID: 11366203 [TBL] [Abstract][Full Text] [Related]
5. On the trail of fugitive fat: the chase turns to NRTIs. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):24-43. PubMed ID: 11366871 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of treatment-induced lipid abnormalities and lipodystrophy. Smith D J HIV Ther; 2001 May; 6(2):25-7. PubMed ID: 11501199 [No Abstract] [Full Text] [Related]
7. Body composition changes with protease therapy. Berger D Posit Aware; 1998; 9(5):47. PubMed ID: 11365895 [TBL] [Abstract][Full Text] [Related]
9. Toxicity of antiretroviral therapy and implications for drug development. Carr A Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812 [No Abstract] [Full Text] [Related]
10. Lipodrama. Horn T Res Initiat Treat Action; 1999 Dec; 5(5):13-5. PubMed ID: 11366885 [TBL] [Abstract][Full Text] [Related]
12. [Lipodystrophy and metabolic disorders in anti-HIV therapy]. Behrens GM; Stoll M; Schmidt RE MMW Fortschr Med; 2000 Mar; 142 Suppl 1():68-71. PubMed ID: 10863318 [TBL] [Abstract][Full Text] [Related]
13. [Effects of high grade antiretroviral therapy on body fat distribution and metabolism]. Schwenk A Zentralbl Gynakol; 1999; 121(11):552-3. PubMed ID: 10612226 [No Abstract] [Full Text] [Related]
14. Adverse drug reactions to protease inhibitors. Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251 [TBL] [Abstract][Full Text] [Related]
15. Are changes in body shape linked to viral load. TreatmentUpdate; 1999 Jun; 11(4):4-5. PubMed ID: 11366791 [TBL] [Abstract][Full Text] [Related]
16. New anti-HIV drug interactions, toxicities, and dosing options. Bartnof HS BETA; 1999; 12(4):60-3, 66. PubMed ID: 11367260 [TBL] [Abstract][Full Text] [Related]
17. Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection. Holstein A; Plaschke A; Egberts EH Exp Clin Endocrinol Diabetes; 2001; 109(8):389-92. PubMed ID: 11748485 [TBL] [Abstract][Full Text] [Related]
18. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors. Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387 [TBL] [Abstract][Full Text] [Related]
19. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA AIDS; 1998 May; 12(7):F51-8. PubMed ID: 9619798 [TBL] [Abstract][Full Text] [Related]
20. [Facial lipodystrophy in patients with HIV infections troublesome to treat]. Walther RA Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]